Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
VMC / Vulcan Materials Co. null (Current Report)

2018-07-10 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
VMC

1
VMC / Vulcan Materials Co. 11-K

2018-06-21 sec.gov
2017 401K 
VMC

1
VMC / Vulcan Materials Co. 11-K

2018-06-21 sec.gov
2017 CMG 
VMC

1
VMC / Vulcan Materials Co. 8-K (Current Report)

2018-06-11 sec.gov
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549
VMC

1
VMC / Vulcan Materials Co. null

2018-05-31 sec.gov
begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"[email protected](# @;V)J#3P\+TQI;F5A8F)D [email protected]&)@8)H.(ADKP&0^B&29 A:_""*9IX+9Y6#V0C!9"1:Y!V:[email protected][email protected]"2C MJ#38A [email protected]^?_<- 8FH/GW02) ,2J3_QD8IWT""# ZAT.+ T*96YD
VMC

1
VMC / Vulcan Materials Co. null

2018-05-31 sec.gov
CORRESP John R. McPherson
VMC

1
VMC / Vulcan Materials Co. null

2018-05-31 sec.gov
begin 644 filename1.pdf M)5!$1BTQ+C4-"B6UM;6U#0HQ(# @;V)J#0H\/"]4>7!E+T-A=&%L;V7!E+U!A9V5S+T-O=6YT(#$O2VED%[email protected]," P(#8Q,B W.3)=("]#;VYT96YT(/_A/@U2$=.B*%+2
VMC

1000
Tracking Dan Loeb's Third Point Portfolio - Q1 2018 Update

2018-05-22 seekingalpha
Dan Loeb's 13F portfolio value decreased from $13.86B to $13.32B this quarter. The number of positions decreased from 44 to 40.
PCG ATHTF STZ.B TWX CVS CRM SHW GGAL HON AABA AVGO DOW DOV MELI MAC AET MMM PBF GD TPRE WP KDMN UTX STZ BKI TWC BABA DVMT GOOGL MSFT APY MHK QCOM GRBK MGM FB DOV.WI LEN NXPI PAM PE NFLX PF GOOG BAX LEN.B MPC PAGS ADBE SPGI RSPP VMC MON ICE SWN HON EA WYNN LYB FTI.WI FMC ANTM DWDP BID NEXA BLK XRAY T SUPV DHR ANTX

16
Home Repair Projects And Eventual Infrastructure Spending Will Benefit These 5 Housing-Related Stocks

2018-05-20 seekingalpha
New home construction peaked in mid-2006, and now that millions of homes are 12 or more years old, repairs are needed.
AWI LII VMC OC MAS

1
VMC / Vulcan Materials Co. FORM 8-K (Current Report)

2018-05-16 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION<
VMC

42
US Concrete: Rainy Days Are Over, 30%-40% Upside For This Firm

2018-05-14 seekingalpha
US Concrete has sold off nearly 30% since its 2018 high early in January. This is due to earnings misses and a sell-off in Trump Trade infrastructure firms.
FB POLMF VMC SUM CX THS MLM USCR

1
VMC / Vulcan Materials Co. 10-Q (Quarterly Report)

2018-05-04 sec.gov
20180331 Q1 UNITE
VMC

25
Thursday’s Biggest Winners and Losers in the S&P 500

2018-05-03 247wallst
Thursday was a down day for the broad U.S. markets. All the exchanges took a dip early in the session but seemingly recovered by then, although not ending on a positive note. Crude oil made another gain in the session, closing in on $70. The S&P 500 sectors were mostly negative. The most positive sectors were materials, technology, and industrials up 0.4%, 0.3% and 0.2%, respectively. The worst performing sectors were health care and financials each down 0.
VMC CAH

5
VMC / Vulcan Materials Co. (Holding Co.) 8-K (Current Report)

2018-04-12 sec.gov
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549
VMC

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

8h - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

9h - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to VMC / Vulcan Materials Co. on message board site Silicon Investor.

AVMC - aVinci Media Corporation AVMC - aVinci Media Corp.
CUSIP: 929160109